Hodgkin Lymphoma Clinical Trials
Hodgkin Lymphoma clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for hodgkin Lymphoma. Corterve aggregates actively recruiting Hodgkin Lymphoma studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.
Recruiting Hodgkin Lymphoma studies
- A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and NivolumabNCT05675410PHASE3National Cancer Institute (NCI)Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8Birmingham, Alabama
- Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology ClinicsNCT06418204Wake Forest University Health SciencesBreast CarcinomaFairbanks, Alaska
- A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin LymphomaNCT05533775PHASE1, PHASE2Hoffmann-La RocheMature B-Cell Non-Hodgkin LymphomaBirmingham, Alabama
- Emapalumab Prevention of CAR-T Cell Associated ToxicitiesNCT06550141PHASE2Marcela V. Maus, M.D.,Ph.D.Large B-cell LymphomaBoston, Massachusetts
- Trial of ONC-PluReceptor NK Cells With Epcoritamab and Tafasitamab for Patients With Recurrent or Refractory B-cell Non-Hodgkin LymphomaNCT07283679PHASE1, PHASE2M.D. Anderson Cancer CenterRecurrent B-Cell Non-Hodgkin LymphomaHouston, Texas
- Loncastuximab Tesirine and Mosunetuzumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell LymphomaNCT05672251PHASE2City of Hope Medical CenterRecurrent Diffuse Large B-Cell LymphomaDuarte, California
- A Study of ARC-02 in B-cell NHLNCT07691606PHASE1Taiho Oncology, Inc.B-cell Non Hodgkin LymphomaLos Angeles, California
- A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell MalignanciesNCT05006716PHASE1, PHASE2BeOne MedicinesB-cell MalignancyBirmingham, Alabama
- A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)NCT06173518PHASE1Autolus LimitedRelapsed or Refractory B Cell Acute Lymphoblastic LeukemiaAurora, Colorado
- Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific AntibodiesNCT06398457EARLY_PHASE1Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsHematologic MalignancyBaltimore, Maryland
- Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell TherapyNCT06834373PHASE2Mayo ClinicLarge B-Cell Lymphoma With IRF4 RearrangementScottsdale, Arizona
- Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell LymphomaNCT04803201PHASE2Alliance for Clinical Trials in OncologyAngioimmunoblastic T-cell LymphomaLittle Rock, Arkansas
Hodgkin Lymphoma trials by state
Hodgkin Lymphoma trials by metro
Frequently asked questions
- How do I find recruiting Hodgkin Lymphoma clinical trials?
- Browse the actively recruiting Hodgkin Lymphoma studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.
- Are Hodgkin Lymphoma clinical trials free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- Who can take part in a Hodgkin Lymphoma clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.